Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Amazing Meds vs T2D.com

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.5

Amazing Meds

Best for patients seeking compounded retatrutide access (with eyes open about regulatory status)

Starting at $199/mo

CompoundedSemaglutideTirzepatideRetatrutide
Visit Amazing Meds
6.1

T2D.com

Best for diabetic GLP-1 access

Starting at $999/mo

CompoundedSemaglutideTirzepatidePrescriber Included
Visit T2D.com

Side-by-Side Comparison

FeatureAmazing MedsT2D.com
Overall Score7.5/106.1/10
Starting Price$199/mo$999/mo
Customer Rating
Features6 features7 features
States Available501
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Amazing Meds

Pros

  • One of the very few US clinics offering compounded retatrutide
  • Board-certified D.O. medical director
  • Limited insurance acceptance (Cigna, BCBS)
  • Free consultations

Cons

  • Compounded retatrutide is regulatorily ambiguous (Phase 3 investigational drug)
  • Lower trust score because retatrutide is not FDA-approved and lacks the safety dataset of approved GLP-1s

T2D.com

Pros

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

Cons

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro

Our Verdict

Winner: Amazing MedsScore: 7.5/10

Amazing Meds edges out T2D.com with a higher overall score of 7.5/10 and is particularly strong for patients seeking compounded retatrutide access (with eyes open about regulatory status). T2D.com remains a solid alternative, especially if you're looking for diabetic GLP-1 access.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.